Effect of green tea extract on arterial stiffness, lipid profile and sRAGE in patients with type 2 diabetes mellitus: a randomised, double-blind, placebo-controlled trial

Autor:	Esther N Sanchez-Rodriguez, Maricruz Barocio-Pantoja, Leonel García-Benavides, David Cardona-Müller, Walter A Trujillo-Rangel, Mariana Rodríguez-De la Cerda, Fernando Grover-Páez, Carlos G Ramos-Becerra, Jhonatan Trujillo-Quiros, Patricia Quezada-Fernández, Sara Pascoe-González, Ernesto Germán Cardona-Muñoz
Rok vydání:	2019
Předmět:	0301 basic medicine Male endocrine system diseases Receptor for Advanced Glycation End Products Placebo-controlled study Green tea extract Gastroenterology Body Mass Index 0302 clinical medicine Glycation Medicine medicine.diagnostic_test S100 Proteins Alanine Transaminase Middle Aged musculoskeletal system Cholesterol Creatinine cardiovascular system Body Composition Female circulatory and respiratory physiology Adult medicine.medical_specialty 030209 endocrinology & metabolism Double blind 03 medical and health sciences Vascular Stiffness Double-Blind Method Internal medicine Diabetes mellitus Humans Aspartate Aminotransferases Triglycerides Glycated Hemoglobin 030109 nutrition & dietetics Tea business.industry Plant Extracts Cholesterol HDL Hemodynamics nutritional and metabolic diseases Type 2 Diabetes Mellitus Polyphenols Cholesterol LDL medicine.disease Lipid Metabolism Diabetes Mellitus Type 2 Dietary Supplements Arterial stiffness business Lipid profile Food Science
Zdroj:	International journal of food sciences and nutrition. 70(8)
ISSN:	1465-3478
Popis:	Type 2 diabetes mellitus (T2DM) is associated with premature atherosclerosis and arterial stiffening due to the accumulation of advanced glycation end-products in vessel walls. Green tea polyphenols are considered cardio-protective substances. In this randomised double-blind placebo-controlled trial (NCT02627898), we evaluated the effect of Green tea extract on arterial stiffness parameters, lipids, body composition and sRAGE levels. Twenty normotensive patients with T2DM treated with the standard therapy and statins, mean age 53.2 ± 9.4 years and mean BMI 30.1 ± 4.5 kg/m
Databáze:	OpenAIRE
Externí odkaz:	https://explore.openaire.eu/search/publication?articleId=doi_dedup___::cda6ff43bf788b8116534ebaa005b0cd https://pubmed.ncbi.nlm.nih.gov/31084381 Zobrazit plný text záznamu Plný text ve formátu PDF Plný text ve formátu HTML
Nepřihlášeným uživatelům se plný text nezobrazuje	K zobrazení výsledku je třeba se přihlásit.